Non-invasive biothermophotonic sensor for blood glucose monitoring

• US 7,729,734 B2
• Filed: 03/07/2006
• Issued: 06/01/2010
• Est. Priority Date: 03/07/2006
• Status: Active Grant

• Current Assignee: Andreas Mandelis, Sergey Telenkov
• Original Assignee: Andreas Mandelis, Sergey Telenkov
• Inventors: Telenkov, Sergey, Mandelis, Andreas
• Primary Examiner(s): Winakur; Eric F
• Assistant Examiner(s): Berhanu; Etsub D
• Application Number:
  US11/368,698
• Publication Number:
  US 20070213607A1
• Time in Patent Office: 1,547 Days
• Field of Search: 600/316, 600/322, 600/365, 356/39
• US Class Current: 600/316
• CPC Class Codes: A61B 5/0091 for mammography
• CPC Class Codes: A61B 5/01 Measuring temperature of body parts ; Diagnostic temperature sensing, e.g. for malignant or inflamed tissue clinical contact thermometers G01K13/20
• CPC Class Codes: A61B 5/14532 for measuring glucose, e.g. by tissue impedance measurement
• CPC Class Codes: A61B 5/7228 Signal modulation applied to the input signal sent to patient or subject; demodulation to recover the physiological signal modulation H03C

Abstract

There is provided a glucose monitoring method and apparatus based on the principle of Wavelength-Modulated Differential Laser Photothermal Radiometry (WM-DPTR). Two intensity modulated laser beams operating in tandem at specific mid-infrared (IR) wavelengths and current-modulated synchronously by two electrical waveforms 180 degrees out-of-phase, are used to interrogate the tissue surface. The laser wavelengths are selected to absorb in the mid infrared range (8.5-10.5 μm) where the glucose spectrum exhibits a discrete absorption band. The differential thermal-wave signal generated by the tissue sample through modulated absorption between two specific wavelengths within the band (for example, the peak at 9.6 and the nearest baseline at 10.5 μm) lead to minute changes in sample temperature and to non-equilibrium blackbody radiation emission. This modulated emission is measured with a broadband infrared detector. The detector is coupled to a lock-in amplifier for signal demodulation. Any glucose concentration increases will be registered as differential photothermal signals above the fully suppressed signal baseline due to increased absorption at the probed peak or near-peak of the band at 9.6 μm at the selected wavelength modulation frequency. The emphasis is on the ability to monitor blood glucose levels in diabetic patients in a non-invasive, non-contacting manner with differential signal generation methods for real-time baseline corrections, a crucial feature toward precise and universal calibration (independent of person-to-person contact, skin, temperature or IR-emission variations) in order to offer accurate absolute glucose concentration readings.

Claims

1. A glucose detection method comprising the steps of:

a) providing first and second sources of radiation, said first and second sources generating first and second beams, respectively, wherein said first source of radiation has a wavelength approximately equal to a peak wavelength of a glucose absorption band, and wherein said second source of radiation has a wavelength off of said peak wavelength of said glucose absorption band;

b) producing a first modulated beam and a second modulated beam by modulating an intensity of said first beam and an intensity of said second beam, respectively;

wherein said first and second modulated beams are modulated at a substantially equal frequency, and wherein a phase of said first modulated beam differs from a phase of said second modulated beam by approximately 180 degrees;

c) substantially equalizing an intensity of said first modulated beam and an intensity of said second modulated beam;

d) directing said first and second modulated beams to co-linearly irradiate a tissue,

e) obtaining a signal by detecting blackbody radiation emission radiated by said tissue with a phase-sensitive detection system comprising a thermal detector, wherein a reference signal for said phase-sensitive detection is provided at said frequency; and

f) correlating said signal with a concentration of glucose in said tissue.

2. The method according to claim 1 wherein said first and second sources of radiation each have a wavelength between approximately 8.5 and 10.5 μ

m.

3. The method according to claim 2 wherein said first source of radiation has a wavelength of approximately 9.6 μ

m and said second source of radiation has a wavelength of approximately 10.5 μ

m.

4. The method according to claim 1 wherein said phase-sensitive detection system comprises a lock-in amplifier.

5. The method according to claim 1 wherein said first and second radiation sources are one of lasers and spectrally filtered halogen lamps.

6. The method according to claim 1 wherein said frequency is selected to lie within the range of 0.1 Hz to 10 kHz.

7. The method according to claim 1 wherein said intensity of said first modulated beam and said intensity of said second modulated beam is equalized by one of using a neutral density filter and adjusting a current of one of said sources of radiation.

8. The method according to claim 1 wherein said step of correlating said signal with a concentration of glucose in said tissue comprises comparing said signal with a signal obtained from normal tissue.

9. The method according to claim 1 wherein said modulation is achieved by one of driving said first and second sources of radiation with electrical waveforms, mechanical chopping of said first and second beams, acousto-optic modulating of said first and second beams and electro-optical modulating of said first and second beams.

10. The method according to claim 1 wherein said step of directing said first and second modulated beams to co-linearly irradiate said tissue is performed using one of a beam combiner in combination with a mid-infrared lens and optical fibers fitted with a beam combiner in combination with an optical lens at a tip of each said optical fibers.

11. The method according to claim 1 wherein said step of detecting said emission radiated by said tissue comprises collecting said radiated emission with one of solid angle and reflectivity optimized curved mirrors and a mid-IR collecting fiber optic system.

12. The method according to claim 1 further comprising sending said signal to a computer for recording and processing.

13. An apparatus for detecting glucose, said apparatus comprising:

a) first and second sources of radiation, said sources generating first and second beams, respectively, wherein said first source of radiation has a wavelength approximately equal to a peak wavelength of a glucose absorption band, and wherein said second source of radiation has a wavelength off of said peak wavelength of said glucose absorption band;

b) modulation means for modulating an intensity of said first beam and an intensity of said second beam, wherein said modulation means is configured to modulate said first and second beams at a substantially equal frequency, said modulation means being further configured to produce a difference in phase between said first and second modulated beams of approximately 180 degrees;

c) equalizing means for substantially equalizing a power of said first modulated beam and said second modulated beam;

d) optical means for directing said first and second modulated beams to co-linearly irradiate a tissue,

e) collection means for collecting thermal power radiated by said tissue;

f) a phase-sensitive detection system comprising a thermal detector configured to detect said collected thermal power, said phase-sensitive detection system receiving as an input a reference signal at said frequency; and

g) means for recording and processing said signal.

14. The apparatus according to claim 13 wherein said first and second sources of radiation each have a wavelength between approximately 8.5 and 10.5 μ

m.

15. The apparatus according to claim 14 wherein said first source of radiation has a wavelength of approximately 9.6 μ

m and said second source of radiation has a wavelength of approximately 10.5 μ

m.

16. The apparatus according to claim 13 wherein said phase-sensitive detection system comprises a lock-in amplifier.

17. The apparatus according to claim 13 wherein said first and second radiation sources are one of lasers and spectrally filtered halogen lamps.

18. The apparatus according to claim 13 wherein said first and second radiation sources are carbon dioxide lasers.

19. The apparatus according to claim 13 wherein said frequency lies within the range of 0.1 Hz to 10 kHz.

20. The apparatus according to claim 13 wherein said equalizing means comprises one of a neutral density filter and an adjustment of a current of one of said sources of radiation.

21. The apparatus according to claim 13 wherein said modulation means comprises one of means for driving said first and second sources of radiation with electrical waveforms, means for modulating a current of said first and second sources of radiation, mechanical choppers adapted to chop said first and second beams, acousto-optic modulators adapted to modulate said first and second beams, and electro-optical modulators adapted to modulate said first and second beams.

22. The apparatus according to claim 13 wherein said optical means comprises one of a beam combiner in combination with a mid-infrared lens, and optical fibers fitted with a beam combiner in combination with an optical lens at a tip of each said optical fibers.

23. The apparatus according to claim 13 wherein said means for recording and processing said signal comprises a computer.

24. The apparatus according to claim 13 wherein said collection means comprises one of solid angle and reflectivity optimized curved mirrors and a mid-IR collecting fiber optic system.